B. Bourbigot

Statistics

Publications

Citations

1.7K

H-Index

Active since

1984

Affiliations

Hôpital Maison Blanche(Current)

Centre Hospitalier Régional Universitaire de Brest

Novartis (Switzerland)

Hôpital Necker-Enfants Malades

Royal Prince Alfred Hospital

B. Bourbigot is an author at Hôpital Maison Blanche specializing in kidney transplantation, medicine, and immunosuppression in kidney transplantation.

Publications per year

1984–2010

Publications

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text

Life Sciences, Hematology, Immunology +16

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies

Hélio Tedesco‐Silva, Josette Eris, Julio Pascual et al. · American Journal of Transplantation · 2004 · 257 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1

Bernard Charpentier, Lionel Rostaing, F. Berthoux et al. · Transplantation · 2003 · 162 citations

Medicine, Immunology, Nephrology +17

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12

Joseph Lawen, Elizabeth Davies, Georges Mourad et al. · Transplantation · 2003 · 137 citations

Medicine, Immunology, Pharmacology +17

DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1

John M. Kovarik, P. Wolf, J.M. Cisterne et al. · Transplantation · 1997 · 129 citations

Medicine, Immunology, Pharmacology +12

1–5 of 23